Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption
This study is currently recruiting participants.
Study NCT00235573   Information provided by University of Florida
First Received: October 6, 2005   Last Updated: June 23, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vitamin B12 Malabsorption
Additional conditions recognized in this trial
Malabsorption Syndromes
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Metabolic Diseases
Interventions listed in this trial
Vitamin B12 (drug)
Additional drug interventions recognized in this trial
Hydroxocobalamin
Vitamin B 12
Vitamin B Complex
Vitamins
More general drug interventions related to this trial
Growth Substances
Hematinics
Hematologic Agents
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Florida


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services